Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Biotherapeutics
Patents
Academic Access
Technology Licensing
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
05/31/2000
Lexicon Genetics' Knockout Technology Used To Develop First Animal Model for Canavan Disease
05/24/2000
Lexicon Genetics Files Patent Infringement Suit Against Deltagen
05/10/2000
Lexicon Genetics Discovers Gene Controlling Onset Of Aging In Mice
04/28/2000
Lexicon Genetics Announces First Quarter Financial Results
04/14/2000
Lexicon Genetics Announces Issuance of Patent On Novel Cancer Target
04/06/2000
Lexicon Genetics Incorporated Announces Pricing of Initial Public Offering
04/06/2000
Lexicon Genetics Names C. Thomas Caskey, M.D. Chairman
04/06/2000
Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With American Home Products
02/23/2000
Lexicon Genetics Announces OmniBank(R) Internet Universal(TM) Agreement With Boehringer Ingelheim
02/16/2000
Lexicon Genetics Names James R. Piggott, Ph.D. Senior Vice President of Pharmaceutical Biology
«
Start
Prev
31
32
Next
End
»
Page 31 of 32
